Non-opioid Pain Treatment Market

Non-opioid Pain Treatment Market Size, Share, Growth Analysis, By Drug Class(NSAIDs, Selective COX-2 Inhibitors, Non-Selective NSAIDs, Acetaminophen), By Pain Type(Chronic Pain, Neuropathic Pain, Inflammatory Conditions, Post-operative Pain), By Route of Administration(Oral, Injectable, Topical, Others), By Distribution Channel(Hospital Pharmacy, Retail Pharmacy, Others), By Region(North America, Europe, Asia Pacific, Latin America) - Industry Forecast 2024-2031

Report ID: UCMIG35D2130 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Non-opioid Pain Treatment Market Insights

Market Overview:

In 2021, the global non-opioid pain treatment market experienced substantial growth, reaching a valuation of USD 38.64 billion. This growth can be attributed to the rising concerns regarding the opioid epidemic and the need for alternative pain management options. The market expansion is driven by factors such as the increasing prevalence of chronic pain conditions, advancements in non-opioid pain treatments including nonsteroidal anti-inflammatory drugs (NSAIDs), physical therapy, and alternative therapies, as well as the growing focus on multimodal approaches to pain management.

Non-opioid Pain Treatment Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Services by segment aggregation, the contribution of the Health Care Services in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



The market for Non-opioid Pain Treatment was estimated to be valued at US$ XX Mn in 2021.

The Non-opioid Pain Treatment Market is estimated to grow at a CAGR of XX% by 2028.

The Non-opioid Pain Treatment Market is segmented on the basis of Drug Class, Pain Type, Route of Administration, Distribution Channel, Region.

Based on region, the Non-opioid Pain Treatment Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Non-opioid Pain Treatment Market are Novartis AG, Teva Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd, Sun Pharmaceutical Industries Ltd, GSK plc., Pfizer Inc., Perrigo Company plc,, LNK International, Inc., Cipla Inc., Johnson & Johnson Services, Inc., Pacira Pharmaceuticals, Inc., Pierrel .

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.


Feedback From Our Clients

Non-opioid Pain Treatment Market

Product ID: UCMIG35D2130